Epsilogen, the global leader in the development of immunoglobulin E (IgE) antibody therapeutics, today announces that it has completed the acquisition of TigaTx, Inc., a biotechnology company ...

Epsilogen completes acquisition of TigaTx to create world’s leading pan-isotype cancer antibody company: London Tuesday, April 8, 2025, 10:00 Hrs [IST] Epsilogen, the global lea ...

The human immune system has evolved five main antibody isotypes (IgG, IgM, IgE, IgA and IgD) which it can call upon depending upon the challenge faced. All cancer antibodies and antibody ...

The body has five different types of antibodies, also known as immunoglobulins. IgA, IgD, IgG, IgE, and IgM are different immunoglobulin isotypes. Immunoglobin A (IgA) defends against infection by ...

Despite over a century of research, Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), continues to kill 1.5 million people annually. Though less than 10% of infected ...

IgEG antibodies which combine IgE and IgG functionality into a single antibody molecule Bispecific IgEs and IgEGs which can bind two different antigens simultaneously IgA 3.0, an engineered ...

the global leader in the development of immunoglobulin E (IgE) antibody therapeutics, today announces that it has completed the acquisition of TigaTx, Inc., a biotechnology company developing ...

anti-IgE may inhibit the B cells or even cause their lysis, like anti-IgM or anti-IgG 41,42. Several lines of in vitro and animal model studies strongly suggest that anti-IgE antibodies can ...